BHEL, Hyundai & more: Top stocks on brokers' radar today

Equirus downgraded Protean eGovernance due to losing a key government project, impacting revenue significantly. Jefferies maintains a hold on Divis Laboratories, citing patent challenges and valuation. Kotak has a sell rating on BHEL due to weak execution. CLSA is positive on Hyundai Motors India, while Morgan Stanley downgraded HAL due to concerns about execution guidance.